Itapira, Brazil

Simone Rosatto


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Simone Rosatto

Introduction

Simone Rosatto is a notable inventor based in Itapira, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of fluoroether compounds and the development of ritonavir analogous compounds for HIV treatment. With a total of 2 patents, Rosatto's work has the potential to impact medical practices significantly.

Latest Patents

Rosatto's latest patents include a stable pharmaceutical composition of fluoroether compounds for anesthetic use. This invention focuses on methods for stabilizing fluoroether compounds against degradation by acid substances. The proposed stabilizers, such as propylene glycol and menthol, are essential for preparing stable pharmaceutical compositions. Another significant patent involves a ritonavir analogous compound that exhibits superior activity in inhibiting HIV protease. This invention outlines the preparation of the ritonavir analogous compound and its pharmaceutical applications in treating HIV infection.

Career Highlights

Throughout his career, Rosatto has worked with Cristalia Produtos Quimicos Farmaceuticos Ltda., a company known for its pharmaceutical innovations. His work has contributed to advancements in drug formulations and therapeutic applications.

Collaborations

Rosatto has collaborated with notable individuals in the field, including Maria Alice Bockelmann and Ogari Pacheco. These collaborations have likely enriched his research and development efforts.

Conclusion

Simone Rosatto's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments. His patents reflect a deep understanding of chemical stability and therapeutic efficacy, marking him as a significant figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…